• Submit to Cells Login Register
• MDPI
• Journals A-Z
• For Authors
• For Editors
• About
• Open Access Policy

• Abstract
• Full-Text PDF [448 KB]

• Article Statistics
• Google Scholar
• Order Reprints

• Cite this article
• Export to BibTeX
• Export to EndNote

• [+] on DOAJ
• Lindenmair, A
• Hatlapatka, T
• Kollwig, G
• Hennerbichler, S
• Gabriel, C
• Wolbank, S
• Redl, H
• Kasper, C
• [+] on Google Scholar
• Lindenmair, A
• Hatlapatka, T
• Kollwig, G
• Hennerbichler, S
• Gabriel, C
• Wolbank, S
• Redl, H
• Kasper, C
• [+] on PubMed
• Lindenmair, A
• Hatlapatka, T
• Kollwig, G
• Hennerbichler, S
• Gabriel, C
• Wolbank, S
• Redl, H
• Kasper, C

•  CiteULike
•  Facebook
•  Mendeley
•  Twitter

This article is

• freely available
• re-usable

Cells 2012, 1(4), 1061-1088; doi:10.3390/cells1041061

Review

Mesenchymal Stem or Stromal Cells from Amnion and Umbilical Cord Tissue and Their Potential for Clinical Applications

Andrea Lindenmair ^1,2,† , Tim Hatlapatka ^3,† , Gregor Kollwig ³ , Simone Hennerbichler ^2,4 , Christian Gabriel ^2,4 , Susanne Wolbank ^1,2 , Heinz Redl ^1,2  and Cornelia Kasper ^3,*

¹ Ludwig Boltzmann Institute for Experimental and Clinical Traumatology, AUVA Research Center, Vienna/Linz 1200, Austria ² Austrian Cluster for Tissue Regeneration, Austria ³ Department of Biotechnology, University of Natural Resources and Life Sciences, Vienna 1190, Austria ⁴ Red Cross Blood Transfusion Service of Upper Austria, Linz 4020, Austria ^† These authors contributed equally to this work.

* Author to whom correspondence should be addressed.

Received: 4 September 2012; in revised form: 29 October 2012 / Accepted: 5 November 2012 / Published: 12 November 2012

(This article belongs to the Special Issue Tissue and Organ Regeneration)

Download PDF Full-Text [448 KB, uploaded 12 November 2012 09:29 CET]

Abstract: Mesenchymal stem or stromal cells (MSC) have proven to offer great promise for cell-based therapies and tissue engineering applications, as these cells are capable of extensive self-renewal and display a multilineage differentiation potential. Furthermore, MSC were shown to exhibit immunomodulatory properties and display supportive functions through parakrine effects. Besides bone marrow (BM), still today the most common source of MSC, these cells were found to be present in a variety of postnatal and extraembryonic tissues and organs as well as in a large variety of fetal tissues. Over the last decade, the human umbilical cord and human amnion have been found to be a rich and valuable source of MSC that is bio-equivalent to BM-MSC. Since these tissues are discarded after birth, the cells are easily accessible without ethical concerns.

Keywords: MSC; mesenchymal stem cell; mesenchymal stromal cell; amnion; umbilical cord; clinical applications

Article Statistics

Cite This Article